James Van Der Beek says there were no ‘warning signs' before his cancer diagnosis
He emphasized the importance of early screening for colorectal cancer, even without symptoms, as he experienced no warning signs before his diagnosis.
Van Der Beek shared his approach to discussing his illness with his six children, advocating for honesty tailored to their understanding.
He recounted how he initially dismissed irregular bowel movements as a minor issue before a gastroenterologist diagnosed him with cancer.
The American Cancer Society recommends regular colorectal cancer screenings begin at age 45 for individuals with average risk.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
Warning issued for common artificial sweetener that can interfere with cancer treatments
A popular sugar substitute may interfere with certain cancer treatments, according to new research. The University of Pittsburgh and UPMC Hillman Cancer Center have released new research suggesting that using sucralose — a popular sugar replacement used by those trying to lose weight or manage their blood sugar levels — may make it harder to the body to respond to certain cancer treatments. According to the research, patients with melanoma and non-small cell lung cancer who consumed high levels of sucralose responded worse to immunotherapy and had worse survival rates than individuals whose diets had low levels of the artificial sweetener. The research also revealed a potential pathway for counteracting the potential negative effects of sucralose. The researchers found supplements that boost the levels of amino acid arginine actually counteracted the negative effects of the sweetener on immunotherapy treatments in mice. That approach could be pursed in further clinical trials to see if it can be used in humans. Doctor Abby Overacre, assistant professor in the Department of Immunology at the University of Pittsbugh and UPMC Hillman said in a statement that finding ways around forcing dietary changes is a worthwhile course of action, especially for cancer patients who are already dealing with the burden of the disease. 'It's easy to say, 'Stop drinking diet soda,' but when patients are being treated for cancer, they are already dealing with enough, so asking them to drastically alter their diet may not be realistic,' she said. 'We need to meet patients where they are. That's why it's so exciting that arginine supplementation could be a simple approach to counteract the negative effects of sucralose on immunotherapy.' The study, which used testing on mice, found the negative effects were potentially caused by disruption to gut bacteria by the artificial sweetener. It found that sucralose caused a shift in the composition of the gut bacteria in mice which allowed for an increase in bacteria that degrade arginine. The increased arginine resulted in reduced levels of the amino acid in blood, tumor fluid, and stool. 'When arginine levels were depleted due to sucralose-driven shifts in the microbiome, T cells couldn't function properly,' Overacre said. 'As a result, immunotherapy wasn't as effective in mice that were fed sucralose.' Diwakar Davar, associate professor of medicine at the University of Pittsburgh and a medical oncologist and hematologist at UPMC Hillman, was a collaborator on the study and noted that the negative effects of sucralose was consistent across a range of treatments for a variety of cancer types and stages. He said that prebiotic supplements could theoretically be developed specifically for cancer patients with high levels of sucralose in their blood to help mitigate the negative effects. The researchers hope to pursue a clinical trial to determine whether or not boosting arginine through supplements will counteract the effects of the sucralose. They also plan to expand their research to look at the effects of other artificial sweeteners — such as aspartame, saccharin, xylitol, and stevia — on the immune system and on cancer treatments.
Reuters
an hour ago
- Reuters
Trump administration blocks funding for CDC health programs, WSJ reports
Aug 1 (Reuters) - U.S. President Donald Trump's administration is blocking funding for a swath of public-health programs run by the Centers for Disease Control and Prevention, the Wall Street Journal reported on Friday, citing unnamed sources. These include youth violence prevention programs, research on preventing gun injuries and deaths and efforts targeting diabetes, chronic kidney disease and tobacco use, according to the report. The money withheld could not be determined, but it could be as high as $200 million, the WSJ reported, citing a person familiar with the matter. The CDC did not immediately respond to a Reuters request for comment. The White House has previously stated its intention to reduce U.S. health spending by more than a quarter next year, with the National Institutes of Health and the Centers for Disease Control and Prevention facing the brunt of billions of dollars in cuts. Earlier this week, Susan Monarez was confirmed as CDC director to lead a downsized agency as the White House moves to slash its budget by nearly $3.6 billion, reducing it to about $4 billion. The cuts follow a layoff plan enacted by U.S. Health Secretary Robert F. Kennedy Jr. that eliminated 2,400 positions in CDC, though roughly 700 of those workers have since been rehired.
Daily Mail
an hour ago
- Daily Mail
Simple body scan can detect if you'll suffer medical emergency that kills 1.2 million Americans
A scan that takes merely 10 minutes may be able to tell you whether you are at risk of having a heart attack and suffering from coronary artery disease. Lynda Hollander, 64, a social worker and runner in West Orange, New Jersey, noticed her cholesterol levels had begun to rise after she hit menopause. She decided to visit a cardiologist, noting that she 'did not want to take a chance' with her health. After reviewing her family's long history of undergoing major surgeries due to heart disease, along with her age, sex, cholesterol and blood pressure levels, Hollander was told she was at the risk of having a heart attack within the next decade. As a result, she began to focus on eating healthier and attempted to lose weight to reduce her cholesterol levels, but her numbers did not improve. Ultimately, her doctor recommended getting a coronary artery calcium scan to find out her risk of developing coronary artery disease (CAD) and having a heart attack. A coronary calcium scan, also known as a heart scan, is a CT scan that provides x-ray images of the blood vessels of the heart. These images can help measure the buildup of hardened deposits of calcium as plaque in the arteries of the heart and help predict the likelihood of developing CAD before any symptoms appear. According to the CDC, over 800,000 Americans either experience a heart attack or stroke each year while about 375,000 people die from CAD annually. About 138,000 Americans died from stroke in 2020 while one American dies of some form of heart disease every 33 seconds and the numbers are rising, especially among young people. A coronary artery calcium scancan tell you whether you are at the risk of having a heart attack and suffering from coronary artery disease CAD is a common heart condition that occurs due to a buildup of calcium, fats and other substances in arteries. This buildup is called plaque, which collects slowly over time in the arteries, causing them to narrow and prevent proper blood flow to and from the heart. Without proper blood flow, the heart becomes more susceptible to an attack and may even experience total failure, which can cause death. However, a coronary calcium scan can help doctors identify the amount of plaque buildup in the arteries and prescribe appropriate treatment to reduce the chances of having an heart attack. Unlike other tests, this scan does not show the rate at which blood is flowing through the arteries. Instead, it only focuses on the amount of plaque in the body. The scan is meant for those who have a family history of early coronary artery disease and have an intermediate risk for a heart attack. It also advised to those who have a history of tobacco use, high cholesterol, diabetes or high blood pressure and those who are obese. A coronary calcium scan is not recommended as a general screening test for those at a high risk for heart attacks. It is also not recommended to those who have already had an attack, have a heart stent or had coronary artery bypass graft surgery before. Based on the amount of plaque in the arteries, experts assign a calcium test score that can range from zero to over 1,000. Those with a score of 100 or less have mild evidence of CAD, those ranking between 100 to 400 have moderate amount of evidence of the disease and those above 400 have strong evidence of CAD in their bodies, according to Cleveland Clinic. Dr Robert Segal, a board-certified cardiologist said: 'I've seen too many patients suffer heart attacks that could have been prevented by knowing their Coronary Artery Calcium (CAC) Score. 'The CAC Score is one of the most powerful tools we have to detect heart disease early, before symptoms appear. I strongly recommend getting a CAC scan. It can truly save lives.' This non-invasive scan is usually not covered by insurance companies and can cost anywhere between $100 to $400. After getting tested, Hollander was told she had a calcium test score ranging in the 50s 'It was the first indication of what was going on inside my arteries,' she told KAFF Health News. Based on this, she was prescribed Crestor (a brand-name prescription drug for statins that help manage cholesterol levels and reduce the risk of heart attacks) three days a week and she self-injects Repatha (a prescription medication used to lower levels of bad cholesterol) twice-a-month.
